Innovative approach to early cancer detection: the Galleri blood test

Against this background, the Galleri test represents an innovative breakthrough. The Galleri analysis is a next-generation screening study designed to detect more than 50 types of cancer at an early stage, including those that are traditionally difficult to identify, such as pancreatic or ovarian cancer.

The Galleri blood test is performed using a simple blood sample. The technology makes it possible to identify molecular signals that indicate the presence of an active oncological process in the body. Moreover, the test can point to the likely origin of the tumor, which speeds up further examinations and the establishment of an accurate diagnosis.

This test is not intended for everyone, but only for people at increased risk of cancer. These include:

• individuals over 50 years old,
• those who have had cancer and have been in remission for more than three years,
• people with multiple cases of cancer in the family,
• patients with hereditary risk factors.

Despite its potential, the Galleri test currently remains an additional tool and does not replace standard screening programs recommended by the Ministry of Health. It is still in the early stages of implementation and requires further data collection.

Statistics show that out of every 200 people:

• 198 will receive a negative result and be considered healthy,
• one will indeed be diagnosed with cancer, and early detection may save their life,
• one more will receive a false-positive result and be sent for additional diagnostics.

In addition to the Galleri analysis, the following technologies are also used and actively developed worldwide:

• Molecular diagnostics (PCR, sequencing) — allows detection of mutations characteristic of certain cancer types.
• PET-CT and MRI — highly accurate imaging methods used to detect tumors and metastases.
• Liquid biopsy — a blood test for circulating tumor cells and DNA, the technology on which the Galleri test is based.
• Artificial intelligence in diagnostics — analysis of large data sets to detect anomalies invisible to the human eye.

The test is available on a paid basis at Ichilov Hospital. To make an appointment or obtain detailed information, you can use the contact form on this page.